Eris Lifesciences logo

Eris Lifesciences shareholders and shareholding pattern

NSE: ERISBSE: 540596Pharmaceuticals & BiotechnologySmall Cap

Last close ₹1,095.50down ₹25.70 (2.29%)BSE ₹1,097.65

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,121.20.

52-week range of traded prices to 23 Oct 2026
₹1,087.90Low, 23 Oct 2026₹1,740.00High, 9 Dec 2025
Market cap
₹15,199 Cr353rd largest listed
P/E
23.6
P/B
3.9
Dividend yield
0.66%
ROE
19.1%
ROCE
13.8%
Debt to equity
0.59
Volume, NSE
37,94348.8% delivered

Who owns Eris Lifesciences, filing by filing

Per cent of the company's shares. Every filing on record, from Jun 2017; the latest is the filing for Sep 2026.

Sep 2026 filing

  • Promoters54.74%
  • Foreign institutions5.74%
  • Indian institutions20.20%
  • GovernmentsNone
  • Individuals and others19.32%

Shareholding pattern, per cent, from Sep 2022

  • Promoters
  • Foreign institutions
  • Indian institutions
  • Governments
  • Individuals and others
Per centJun 2017Filed 30 MarSep 2017Filed 30 MarDec 2017Filed 18 JanMar 2018Filed 13 AprJun 2018Filed 10 JulSep 2018Filed 20 OctDec 2018Filed 11 JanMar 2019Filed 6 AprJun 2019Filed 18 JulSep 2019Filed 16 OctDec 2019Filed 18 JanMar 2020Filed 16 AprJun 2020Filed 18 JulSep 2020Filed 20 OctDec 2020Filed 20 JanMar 2021Filed 20 AprJun 2021Filed 21 JulSep 2021Filed 18 OctDec 2021Filed 21 JanMar 2022Filed 20 AprJun 2022Filed 15 JulSep 2022Filed 12 OctDec 2022Filed 20 JanMar 2023Filed 21 AprJun 2023Filed 10 JulSep 2023Filed 17 OctDec 2023Filed 18 JanMar 2024Filed 16 AprJun 2024Filed 11 JulSep 2024Filed 18 OctDec 2024Filed 20 JanMar 2025Filed 19 AprJun 2025Filed 19 JulSep 2025Filed 18 OctDec 2025Filed 15 JanMar 2026Filed 15 AprJun 2026Filed 18 JulSep 2026Filed 19 Oct
55.93%55.93%55.93%55.93%55.93%55.92%56.04%56.10%56.23%56.23%56.23%55.55%55.55%54.08%54.23%54.13%52.69%52.68%52.66%52.66%52.30%52.29%52.70%52.86%52.86%54.91%54.90%54.90%54.88%54.87%54.86%54.85%54.83%54.85%54.85%53.92%54.14%54.74%
Indian promoters55.93%55.93%55.93%55.93%55.93%55.92%56.04%56.10%56.23%56.23%56.23%55.55%55.55%54.08%54.23%54.13%52.69%52.68%52.66%52.66%52.30%52.29%52.70%52.86%52.86%54.91%54.90%54.90%54.88%54.87%54.86%54.85%54.83%54.85%54.85%53.92%54.14%54.74%
44.07%44.07%44.07%44.06%44.07%44.08%43.96%43.90%43.77%43.77%43.77%44.45%44.45%45.92%45.77%45.87%47.31%47.32%47.34%47.34%47.70%47.71%47.30%47.14%47.14%45.09%45.10%45.10%45.12%45.13%45.14%45.15%45.17%45.15%45.15%46.08%45.86%45.26%
Promoter shares pledgedShare of the promoters' own shares0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%11.37%10.95%10.95%18.51%18.51%18.51%18.51%18.51%16.93%16.92%16.92%16.92%16.85%21.25%
Shares in issue13,75,00,00013,75,00,00013,75,00,00013,75,00,00013,75,05,48613,75,15,46113,75,17,62213,75,19,78313,75,19,78313,75,19,78313,75,19,78313,57,80,65313,57,80,65313,57,80,65313,57,80,65313,57,80,65313,57,80,65313,59,08,58913,59,30,19713,59,30,19713,59,72,68013,59,90,71713,59,90,71713,59,92,23813,59,93,29213,60,23,24813,60,28,28013,60,28,28013,60,75,00813,61,05,79213,61,29,28213,61,62,56913,61,97,32513,62,13,55413,62,16,89113,85,42,88713,85,78,48913,87,38,569
Shares locked in12,15,51,25010,86,25,00010,86,25,00010,86,25,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,00000000000000000000000–––23,06,37223,06,37223,06,372
Promoters' shares locked in7,69,04,5007,69,04,5007,69,04,5007,69,04,5002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,0002,75,00,00000000000000000000000––––––
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Eris Lifesciences shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

ShareholdersJun 2017Filed 30 MarSep 2017Filed 30 MarDec 2017Filed 18 JanMar 2018Filed 13 AprJun 2018Filed 10 JulSep 2018Filed 20 OctDec 2018Filed 11 JanMar 2019Filed 6 AprJun 2019Filed 18 JulSep 2019Filed 16 OctDec 2019Filed 18 JanMar 2020Filed 16 AprJun 2020Filed 18 JulSep 2020Filed 20 OctDec 2020Filed 20 JanMar 2021Filed 20 AprJun 2021Filed 21 JulSep 2021Filed 18 OctDec 2021Filed 21 JanMar 2022Filed 20 AprJun 2022Filed 15 JulSep 2022Filed 12 OctDec 2022Filed 20 JanMar 2023Filed 21 AprJun 2023Filed 10 JulSep 2023Filed 17 OctDec 2023Filed 18 JanMar 2024Filed 16 AprJun 2024Filed 11 JulSep 2024Filed 18 OctDec 2024Filed 20 JanMar 2025Filed 19 AprJun 2025Filed 19 JulSep 2025Filed 18 OctDec 2025Filed 15 JanMar 2026Filed 15 AprJun 2026Filed 18 JulSep 2026Filed 19 Oct
All shareholders88,00153,13036,84133,12931,81431,95931,04429,75829,56731,92533,56829,19534,77242,34744,52141,47046,47749,83354,22357,06151,63948,05546,74645,93144,16942,24546,49651,75344,17646,34653,31450,08752,22559,43854,71351,65650,79849,034
55555555555555555555444445555555555555
Indian promoters55555555555555555555444445555555555555
87,99653,12536,83633,12431,80931,95431,03929,75329,56231,92033,56329,19034,76742,34244,51641,46546,47249,82854,21857,05651,63548,05146,74245,92744,16542,24046,49151,74844,17146,34153,30950,08252,22059,43354,70851,65150,79349,029
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state.

Eris Lifesciences promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Amit Indubhusan Bakshi, 42.96%. The filing names 56 more members with no shares.Promoter buying and selling

Holder
Amit Indubhusan BakshiIndividuals and Hindu undivided families42.96%5,95,96,63619.59%
Inderjeet Singh NegiIndividuals and Hindu undivided families4.28%59,39,83331.69%
Rajendrakumar Rambhai PatelIndividuals and Hindu undivided families4.28%59,39,83431.69%
Kaushal Kamleshkumar ShahIndividuals and Hindu undivided families3.22%44,68,83315.66%
Sarthak NegiIndividuals and Hindu undivided families0.00%1000.00%
Pledged is the share of the holder's own shares pledged to a lender.

Largest public holders of Eris Lifesciences, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Eris Lifesciences

HolderJun 2017Filed 30 MarSep 2017Filed 30 MarDec 2017Filed 18 JanMar 2018Filed 13 AprJun 2018Filed 10 JulSep 2018Filed 20 OctDec 2018Filed 11 JanMar 2019Filed 6 AprJun 2019Filed 18 JulSep 2019Filed 16 OctDec 2019Filed 18 JanMar 2020Filed 16 AprJun 2020Filed 18 JulSep 2020Filed 20 OctDec 2020Filed 20 JanMar 2021Filed 20 AprJun 2021Filed 21 JulSep 2021Filed 18 OctDec 2021Filed 21 JanMar 2022Filed 20 AprJun 2022Filed 15 JulSep 2022Filed 12 OctDec 2022Filed 20 JanMar 2023Filed 21 AprJun 2023Filed 10 JulSep 2023Filed 17 OctDec 2023Filed 18 JanMar 2024Filed 16 AprJun 2024Filed 11 JulSep 2024Filed 18 OctDec 2024Filed 20 JanMar 2025Filed 19 AprJun 2025Filed 19 JulSep 2025Filed 18 OctDec 2025Filed 15 JanMar 2026Filed 15 AprJun 2026Filed 18 JulSep 2026Filed 19 Oct
Lilac Investments LimitedForeign companies–––––––––––––––––––––––––––––7.26%8.79%8.79%8.79%8.78%8.78%8.64%8.63%8.62%
Hetal Rasiklal ShahResident individuals, over ₹2 lakh at face value3.50%3.50%3.50%3.50%3.50%3.50%3.50%3.50%3.48%3.48%2.97%2.97%2.96%2.89%2.85%2.81%2.72%2.69%2.69%2.69%2.68%2.68%2.68%2.68%2.68%2.62%2.58%2.58%2.40%2.20%2.20%2.20%2.18%2.16%2.16%2.12%2.12%2.12%
Bhikhalal Chimanlal ShahResident individuals, over ₹2 lakh at face value8.04%8.04%8.04%8.04%8.04%7.76%7.76%7.76%7.76%7.76%6.60%6.55%6.55%6.55%6.55%6.55%6.53%6.53%6.52%6.52%4.32%4.32%4.32%4.32%4.31%4.30%4.30%2.76%2.76%1.97%1.97%1.97%1.97%1.97%1.97%1.93%1.93%1.93%
Naishadh Vikram ShahResident individuals, over ₹2 lakh at face value–––––––––––––––––––––––––––––––––––1.66%1.66%1.66%
Rakesh ShahResident individuals, over ₹2 lakh at face value–––11.53%11.53%11.53%11.53%11.53%11.53%11.53%11.53%11.55%11.55%11.55%11.55%11.55%11.55%11.54%11.54%11.54%11.53%11.53%11.53%11.53%11.53%4.88%4.88%4.88%4.88%2.92%1.45%1.45%1.45%1.45%1.45%1.43%1.43%1.42%
Emerald Investments LimitedForeign portfolio investors, category I––––––––––2.60%5.51%5.51%5.51%5.51%5.51%5.51%5.50%5.50%5.50%7.58%7.58%7.58%7.58%7.58%7.58%7.58%7.27%7.27%–––––––––
Plutus Wealth Management LlpCompanies–––––––––––––––––––––––––1.10%1.10%–––––––––––
Kuwait Investment Authority Fund 225Foreign portfolio investors, category I–––––––––––––1.11%1.11%–––––––1.47%1.47%1.47%1.10%1.03%–––––––––––
UTI India Dynamic Equity FundForeign portfolio investors, category II––––––––––––––––––1.06%1.00%–1.02%––––––––––––––––
Fundsmith Emerging Equities Trust PlcInstitutions Foreign Portfolio Investor––––––––1.11%1.11%1.11%1.09%1.09%1.09%1.09%1.09%1.09%1.09%––––––––––––––––––––
Abu Dhabi Investment Authority - BehaveInstitutions Foreign Portfolio Investor–1.01%1.01%1.01%1.01%1.01%1.01%1.01%1.01%1.01%1.01%–––––––––––––––––––––––––––
Matthews India FundInstitutions Foreign Portfolio Investor–––1.02%1.42%1.42%1.42%1.42%1.15%–––––––––––––––––––––––––––––
Goldman Sachs India LimitedInstitutions Foreign Portfolio Investor1.99%1.65%1.65%1.37%1.31%1.20%1.20%–––––––––––––––––––––––––––––––
Rakeshbhai Bhikhabhai ShahResident individuals, over ₹2 lakh at face value11.53%11.53%11.53%–––––––––––––––––––––––––––––––––––
Merrill Lynch Markets Singapore Pte. LtdInstitutions Foreign Portfolio Investor1.15%–––––––––––––––––––––––––––––––––––––
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.